CCC
ELV icon

Chesapeake Capital Corp’s Elevance Health ELV Stock Holding History

Chesapeake Capital Corp’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$275K Buy
+711
New +$264K 0.14% 160

Other funds holding ELV

AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
FI
Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Chesapeake Capital Corp's ELV Position: Q2 2026 in Review

Chesapeake Capital Corp opened a new position in Elevance Health (ELV) in Q2 2026: 711 shares worth $275K. The stake represents 0.14% of the portfolio and ranks #160 among its holdings.

637 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Chesapeake Capital Corp held 711 shares of Elevance Health worth $275K as of Q2 2026.
  • Elevance Health was a new Chesapeake Capital Corp position in Q2 2026.
  • Elevance Health made up 0.14% of Chesapeake Capital Corp's portfolio in Q2 2026, its #160 holding.
  • 637 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Chesapeake Capital Corp's 13F filing for Q2 2026, filed 29 Jul 2026.